The expression level of AEBP1 during different grades of glioma was analyzed in two datasets, and the results showed that it was higher in GBM patients than that in lower-grade glioma patients (Figures 2(a) and 2(b)). This evidence concerns the gene AEBP1 and central nervous system cancer.